1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transthyretin Revenue
1.4 Market Analysis by Type
1.4.1 Global Transthyretin Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 AG-10
1.4.3 ALN-TTRsc02
1.4.4 CRX-1008
1.4.5 EDE-1307
1.4.6 Inotersen Sodium
1.4.7 Others
1.5 Market by Application
1.5.1 Global Transthyretin Market Share by Application: 2021-2026
1.5.2 Familial Amyloid Neuropathies
1.5.3 Alzheimer's Disease
1.5.4 Cardomyopathy
1.5.5 Neuropathy
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Transthyretin Market
1.8.1 Global Transthyretin Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Transthyretin Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Transthyretin Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Transthyretin Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Transthyretin Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Transthyretin Sales Volume Market Share by Region (2015-2020)
3.2 Global Transthyretin Sales Revenue Market Share by Region (2015-2020)
3.3 North America Transthyretin Sales Volume
3.3.1 North America Transthyretin Sales Volume Growth Rate (2015-2020)
3.3.2 North America Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Transthyretin Sales Volume
3.4.1 East Asia Transthyretin Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Transthyretin Sales Volume (2015-2020)
3.5.1 Europe Transthyretin Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Transthyretin Sales Volume (2015-2020)
3.6.1 South Asia Transthyretin Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Transthyretin Sales Volume (2015-2020)
3.7.1 Southeast Asia Transthyretin Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Transthyretin Sales Volume (2015-2020)
3.8.1 Middle East Transthyretin Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Transthyretin Sales Volume (2015-2020)
3.9.1 Africa Transthyretin Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Transthyretin Sales Volume (2015-2020)
3.10.1 Oceania Transthyretin Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Transthyretin Sales Volume (2015-2020)
3.11.1 South America Transthyretin Sales Volume Growth Rate (2015-2020)
3.11.2 South America Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Transthyretin Sales Volume (2015-2020)
3.12.1 Rest of the World Transthyretin Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Transthyretin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Transthyretin Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Transthyretin Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Transthyretin Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Transthyretin Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Transthyretin Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Transthyretin Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Transthyretin Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Transthyretin Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Transthyretin Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Transthyretin Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Transthyretin Sales Volume Market Share by Type (2015-2020)
14.2 Global Transthyretin Sales Revenue Market Share by Type (2015-2020)
14.3 Global Transthyretin Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Transthyretin Consumption Volume by Application (2015-2020)
15.2 Global Transthyretin Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Transthyretin Business
16.1 Alnylam Pharmaceuticals Inc
16.1.1 Alnylam Pharmaceuticals Inc Company Profile
16.1.2 Alnylam Pharmaceuticals Inc Transthyretin Product Specification
16.1.3 Alnylam Pharmaceuticals Inc Transthyretin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Neurimmune Holding AG
16.2.1 Neurimmune Holding AG Company Profile
16.2.2 Neurimmune Holding AG Transthyretin Product Specification
16.2.3 Neurimmune Holding AG Transthyretin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Arcturus Therapeutics Inc
16.3.1 Arcturus Therapeutics Inc Company Profile
16.3.2 Arcturus Therapeutics Inc Transthyretin Product Specification
16.3.3 Arcturus Therapeutics Inc Transthyretin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Regeneron Pharmaceuticals Inc
16.4.1 Regeneron Pharmaceuticals Inc Company Profile
16.4.2 Regeneron Pharmaceuticals Inc Transthyretin Product Specification
16.4.3 Regeneron Pharmaceuticals Inc Transthyretin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Ionis Pharmaceuticals Inc
16.5.1 Ionis Pharmaceuticals Inc Company Profile
16.5.2 Ionis Pharmaceuticals Inc Transthyretin Product Specification
16.5.3 Ionis Pharmaceuticals Inc Transthyretin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Prothena Corp Plc
16.6.1 Prothena Corp Plc Company Profile
16.6.2 Prothena Corp Plc Transthyretin Product Specification
16.6.3 Prothena Corp Plc Transthyretin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Pfizer Inc
16.7.1 Pfizer Inc Company Profile
16.7.2 Pfizer Inc Transthyretin Product Specification
16.7.3 Pfizer Inc Transthyretin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Transthyretin Manufacturing Cost Analysis
17.1 Transthyretin Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Transthyretin
17.4 Transthyretin Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Transthyretin Distributors List
18.3 Transthyretin Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Transthyretin (2021-2026)
20.2 Global Forecasted Revenue of Transthyretin (2021-2026)
20.3 Global Forecasted Price of Transthyretin (2015-2026)
20.4 Global Forecasted Production of Transthyretin by Region (2021-2026)
20.4.1 North America Transthyretin Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Transthyretin Production, Revenue Forecast (2021-2026)
20.4.3 Europe Transthyretin Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Transthyretin Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Transthyretin Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Transthyretin Production, Revenue Forecast (2021-2026)
20.4.7 Africa Transthyretin Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Transthyretin Production, Revenue Forecast (2021-2026)
20.4.9 South America Transthyretin Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Transthyretin Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Transthyretin by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Transthyretin by Country
21.2 East Asia Market Forecasted Consumption of Transthyretin by Country
21.3 Europe Market Forecasted Consumption of Transthyretin by Countriy
21.4 South Asia Forecasted Consumption of Transthyretin by Country
21.5 Southeast Asia Forecasted Consumption of Transthyretin by Country
21.6 Middle East Forecasted Consumption of Transthyretin by Country
21.7 Africa Forecasted Consumption of Transthyretin by Country
21.8 Oceania Forecasted Consumption of Transthyretin by Country
21.9 South America Forecasted Consumption of Transthyretin by Country
21.10 Rest of the world Forecasted Consumption of Transthyretin by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer